News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioSante Pharmaceuticals, Inc. (BPA) Signs Oral Contraceptive License with Pantarhei Bioscience


5/7/2007 1:08:14 PM

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (Amex: BPA) today announced that it has signed an exclusive agreement with Pantarhei Bioscience, a Netherlands-based pharmaceutical company for the development and marketing of an oral contraceptive in the United States. BioSante will co-fund the early development of the oral contraceptive up to $1.0 million. Pantarhei will be responsible for all other expenses to develop and market the product.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES